Biopsies show unique aggregations of CD38+ tumor infiltrating lymphocytes (TILs) in HCC, and the presence of larger numbers of CD38+ TILs is associated with improved effectiveness of immunotherapy in HCC [6,7]. This evidence concerns the gene CD38 and neoplasm.